Praxis Precision Medicines, Inc. (PRAX)
USD 30.88
(-5.42%)
USD 30.88
(-5.42%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -84.31 Million USD | 272.08% |
| 2022 | -1.17 Million USD | 26.54% |
| 2021 | -1.59 Million USD | -113.67% |
| 2020 | -746 Thousand USD | -9.87% |
| 2019 | -679 Thousand USD | -67800.0% |
| 2018 | -1000.00 USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 250 Thousand USD | -21.63% |
| 2024 Q1 | 319 Thousand USD | -21.04% |
| 2023 Q3 | 147 Thousand USD | -68.66% |
| 2023 Q1 | 376 Thousand USD | 224.92% |
| 2023 FY | 2.01 Million USD | 272.08% |
| 2023 Q4 | 404 Thousand USD | 174.83% |
| 2023 Q2 | 469 Thousand USD | 24.73% |
| 2022 FY | -1.17 Million USD | 26.54% |
| 2022 Q4 | -301 Thousand USD | -3.08% |
| 2022 Q3 | -292 Thousand USD | 4.26% |
| 2022 Q2 | -305 Thousand USD | -11.72% |
| 2022 Q1 | -273 Thousand USD | 51.51% |
| 2021 FY | -1.59 Million USD | -113.67% |
| 2021 Q1 | -206 Thousand USD | 0.0% |
| 2021 Q2 | -319 Thousand USD | -54.85% |
| 2021 Q3 | -506 Thousand USD | -58.62% |
| 2021 Q4 | -563 Thousand USD | -11.26% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | -746 Thousand USD | -9.87% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | -679 Thousand USD | -67800.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2018 FY | -1000.00 USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | 321.746% |
| Alkermes plc | 1.37 Billion USD | 106.134% |
| Agenus Inc. | 139.61 Million USD | 160.394% |
| Aptorum Group Limited | -1.11 Million USD | -7464.359% |
| Ardelyx, Inc. | 106.66 Million USD | 179.053% |
| Dyadic International, Inc. | 922.95 Thousand USD | 9235.745% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 500.356% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -48125.551% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -531.232% |
| Novavax, Inc. | 639.93 Million USD | 113.176% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -80.019% |
| Pyxis Oncology, Inc. | -2 Million USD | -4115.95% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -16217.301% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 542.782% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -190718.774% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -15899.81% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 14.15% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 10613.591% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -102728.049% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 162.334% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 1171.262% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 13.028% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 105.555% |
| AlloVir, Inc. | -398 Thousand USD | -21085.678% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 135.026% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 19986.557% |
| Bicycle Therapeutics plc | -129.52 Million USD | 34.899% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 70365.833% |
| ChromaDex Corporation | 50.78 Million USD | 266.048% |
| Chimerix, Inc. | 324 Thousand USD | 26124.383% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -170.534% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -8.661% |
| CRISPR Therapeutics AG | 240.95 Million USD | 134.994% |
| Precision BioSciences, Inc. | 40.47 Million USD | 308.339% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 14.103% |
| Fortress Biotech, Inc. | 57.85 Million USD | 245.747% |
| Fortress Biotech, Inc. | 57.85 Million USD | 245.747% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 608.651% |
| ImmuCell Corporation | 4.39 Million USD | 2017.961% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 20.546% |
| Immix Biopharma, Inc. | -5468.00 USD | -1541944.623% |
| Incyte Corporation | 3.44 Billion USD | 102.451% |
| Innoviva, Inc. | 261.06 Million USD | 132.298% |
| IO Biotech, Inc. | -756 Thousand USD | -11053.307% |
| Jaguar Health, Inc. | 7.72 Million USD | 1191.649% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -12598.645% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 170.411% |
| ContextLogic Inc. | 59 Million USD | 242.914% |
| MiMedx Group, Inc. | 266.84 Million USD | 131.599% |
| MEI Pharma, Inc. | 49.32 Million USD | 270.939% |
| NextCure, Inc. | -3.68 Million USD | -2188.789% |
| Onconetix, Inc. | -1.12 Million USD | -7380.626% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -191.076% |
| Opthea Limited | 21.72 Thousand USD | 388309.024% |
| Psyence Biomedical Ltd. | -240.00 USD | -35132816.667% |
| Vaxcyte, Inc. | -75 Million USD | -12.425% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -146986.837% |
| Precigen, Inc. | 106 Thousand USD | 79646.226% |
| Pharming Group N.V. | 220.1 Million USD | 138.309% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 16472.621% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 8456.69% |
| PureTech Health plc | -1.6 Million USD | -5160.075% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 176.813% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 53.52% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -86.032% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -283.495% |
| Acelyrin, Inc. | -115 Thousand USD | -73220.87% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -838811.551% |
| Summit Therapeutics Inc. | -2.05 Million USD | -4013.122% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -14666.9% |
| Senti Biosciences, Inc. | -2.68 Million USD | -3042.713% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 2181.437% |
| Elevation Oncology, Inc. | -39 Thousand USD | -216102.564% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -1657.378% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -2038.964% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 389.468% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 17099.798% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -153207.273% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 180.999% |
| Seer, Inc. | 7.02 Million USD | 1299.929% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 2025.971% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 491.362% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -71060.679% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -58740.483% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 13945.484% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 169.989% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 126.881% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -1686280.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 3375.796% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -166078.557% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 386.926% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -36244.397% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -17038.008% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -1087.926% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -17668.389% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -810659.615% |
| Soligenix, Inc. | 97.31 Thousand USD | 86748.991% |
| Century Therapeutics, Inc. | -10.8 Million USD | -680.081% |
| Kura Oncology, Inc. | -849 Thousand USD | -9831.567% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -25.654% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -57259.864% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 185.137% |
| Autolus Therapeutics plc | -4.86 Million USD | -1632.464% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 303.738% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -50089.881% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 189.016% |
| GRI Bio, Inc. | 10.84 Million USD | 877.779% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 3419.664% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -870.634% |
| IGM Biosciences, Inc. | -211.66 Million USD | 60.163% |
| INmune Bio, Inc. | 155 Thousand USD | 54499.355% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 236.132% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -5497.79% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -12903.081% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -287933.75% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 21074.876% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -4124.399% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -26838.978% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 189.263% |
| Verastem, Inc. | -62 Thousand USD | -135898.387% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 3562.793% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -32206.13% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 2885.563% |
| Histogen Inc. | 3.76 Million USD | 2337.172% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 14734.168% |
| Surrozen, Inc. | -27.23 Million USD | -209.655% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1464.65% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -6898.124% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -228.767% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 520.502% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -4258435.354% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1489.929% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -125503.67% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 154.473% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 57931.962% |
| Apollomics, Inc. | 127 Thousand USD | 66492.913% |
| Amarin Corporation plc | 165.54 Million USD | 150.935% |
| Mesoblast Limited | -9.81 Million USD | -759.083% |
| Turnstone Biologics Corp. | 16.5 Million USD | 610.838% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 23.686% |
| Synaptogenix, Inc. | -6347.00 USD | -1328385.899% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -165231.373% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 152.254% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 104.797% |
| Better Therapeutics, Inc. | -2.72 Million USD | -2989.74% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 24.823% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 124.94% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -739021.669% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -1246.949% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -7510.018% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 1252.214% |
| Insmed Incorporated | 239.63 Million USD | 135.186% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 2456.596% |
| OmniAb, Inc. | 14.66 Million USD | 674.889% |
| Alector, Inc. | -95.05 Million USD | 11.293% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 167.122% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -94.002% |
| Zai Lab Limited | 170.9 Million USD | 149.337% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 202.983% |
| Aura Biosciences, Inc. | -1.29 Million USD | -6411.12% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 64960.769% |
| Immunic, Inc. | -111 Thousand USD | -75863.063% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 631.847% |
| Veracyte, Inc. | 248.14 Million USD | 133.979% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 98.794% |
| FibroGen, Inc. | 128.9 Million USD | 165.412% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -14950077.305% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -622.721% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 102.481% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 21775.835% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 123.729% |
| TG Therapeutics, Inc. | 219.1 Million USD | 138.483% |
| Galecto, Inc. | -830 Thousand USD | -10058.916% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -5988.014% |
| Fortrea Holdings Inc. | 424 Million USD | 119.887% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 2.145% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -14771.076% |
| XBiotech Inc. | -1.74 Million USD | -4734.805% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -7510.018% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -81.444% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -11.631% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 214.871% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 601.809% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 121.674% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -69.837% |
| Vaxxinity, Inc. | -2.23 Million USD | -3674.351% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 125.805% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -644.615% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 444.849% |
| NexImmune, Inc. | -1.02 Million USD | -8126.469% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 1561562.963% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -1086.646% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.746% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -126075.049% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -2274.514% |
| Ainos, Inc. | -253.73 Thousand USD | -33131.389% |
| Pluri Inc. | 322 Thousand USD | 26286.025% |
| Prothena Corporation plc | -129.2 Million USD | 34.738% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 267.22% |
| Celularity Inc. | 6.75 Million USD | 1348.246% |
| Rallybio Corporation | -150 Thousand USD | -56112.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | -158.592% |
| MeiraGTx Holdings plc | 287 Thousand USD | 29479.443% |
| Omeros Corporation | -69.77 Million USD | -20.837% |
| Humacyte, Inc. | -76.55 Million USD | -10.149% |
| Immunocore Holdings plc | 248.39 Million USD | 133.946% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -455.864% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 235.166% |
| Blueprint Medicines Corporation | 236.58 Million USD | 135.64% |
| CalciMedica, Inc. | -58 Thousand USD | -145277.586% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -5812.973% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 390.205% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -2864.803% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -173.186% |
| Pulmatrix, Inc. | -8.22 Million USD | -925.779% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -7106.752% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -21032.581% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 78.857% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 3137.882% |
| Cytokinetics, Incorporated | -322.59 Million USD | 73.862% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 9880.595% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -24626.979% |
| Vor Biopharma Inc. | -3.49 Million USD | -2314.633% |
| Roivant Sciences Ltd. | 109.23 Million USD | 177.19% |
| Evogene Ltd. | 1.39 Million USD | 6127.091% |
| ProKidney Corp. | -3.16 Million USD | -2560.745% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -92.018% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1329.678% |
| CorMedix Inc. | -205.56 Thousand USD | -40918.768% |
| BioLineRx Ltd. | 1.1 Million USD | 7710.018% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -7.179% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -255412.121% |
| Atai Life Sciences N.V. | -5000.00 USD | -1686280.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -69093.904% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -87732.292% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -5970.482% |
| Sagimet Biosciences Inc. | 2 Million USD | 4315.95% |
| MediciNova, Inc. | 979.7 Thousand USD | 8706.57% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -89074.554% |
| GeoVax Labs, Inc. | -20.72 Million USD | -306.93% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 134.481% |
| Biomea Fusion, Inc. | -4.2 Million USD | -1907.117% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 109.666% |
| Mereo BioPharma Group plc | 7.42 Million USD | 1235.457% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -27099.677% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -702558.333% |
| Absci Corporation | -41.84 Million USD | -101.484% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1686280.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -10.404% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -3326.209% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 139.45% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -8860.574% |
| Allakos Inc. | -6.14 Million USD | -1273.05% |
| Imunon, Inc. | -720 Thousand USD | -11610.891% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -22.209% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 117.718% |
| BioAtla, Inc. | -103.73 Million USD | 18.714% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -739021.669% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -47270.225% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 65.275% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -27012.219% |
| XOMA Corporation | 3.86 Million USD | 2283.864% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -20.31% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 669.954% |
| aTyr Pharma, Inc. | -2.38 Million USD | -3430.946% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 776.717% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -290655.172% |
| Viridian Therapeutics, Inc. | -1 Million USD | -8264.98% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 648607792.308% |
| Akari Therapeutics, Plc | -4000.00 USD | -2107875.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 113.239% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 43405.36% |
| UroGen Pharma Ltd. | 73.35 Million USD | 214.951% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -215.872% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 726361.843% |
| Orgenesis Inc. | -5.72 Million USD | -1372.821% |
| Entera Bio Ltd. | -56 Thousand USD | -150469.643% |
| GH Research PLC | -315 Thousand USD | -26667.937% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -44513.228% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -15960.762% |
| Xencor, Inc. | -85.26 Million USD | 1.104% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -38057.365% |
| Replimune Group, Inc. | -2.65 Million USD | -3075.857% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -8321.491% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 147.412% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 43405.36% |
| Portage Biotech Inc. | -54 Thousand USD | -156046.296% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -89074.554% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -22265.782% |
| OncoCyte Corporation | 413 Thousand USD | 20516.223% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -1875739.822% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -37981431.532% |
| Purple Biotech Ltd. | -196 Thousand USD | -42919.898% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 1040.221% |
| scPharmaceuticals Inc. | 9.78 Million USD | 961.981% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -707.27% |
| HilleVax, Inc. | -2.15 Million USD | -3810.9% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -86826.804% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -561876.806% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -12522.605% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -366504.348% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -1123230.704% |
| Savara Inc. | -44.26 Million USD | -90.5% |
| Curis, Inc. | 9.81 Million USD | 959.433% |
| Daré Bioscience, Inc. | 2.76 Million USD | 3144.533% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -67469.798% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -4776.75% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -36882.018% |
| BeiGene, Ltd. | 2.07 Billion USD | 104.056% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -2915.809% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 78.903% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 248.742% |
| Erasca, Inc. | -3.73 Million USD | -2159.352% |
| bluebird bio, Inc. | -4.03 Million USD | -1992.283% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -298712.815% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 104.428% |
| DBV Technologies S.A. | 15.72 Million USD | 636.108% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -298712.815% |
| Moderna, Inc. | 2.15 Billion USD | 103.913% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -9115.191% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 1153.198% |
| Molecular Templates, Inc. | 50.39 Million USD | 267.316% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -15631.157% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 163.024% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -1255.175% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -114.318% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 24.124% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -2250.028% |
| MacroGenics, Inc. | 50.52 Million USD | 266.879% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -1282.732% |
| Prime Medicine, Inc. | -147.9 Million USD | 42.991% |
| Aditxt, Inc. | -111.66 Thousand USD | -75414.061% |
| Adagene Inc. | 18.11 Million USD | 565.555% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 17378.484% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 160.141% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 153.422% |
| SciSparc Ltd. | 2.19 Million USD | 3939.663% |
| Vericel Corporation | 135.57 Million USD | 162.193% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -336516.232% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -272054.8% |
| Generation Bio Co. | -73.91 Million USD | -14.082% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -19194.966% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 254.377% |
| Invivyd, Inc. | -2.02 Million USD | -4057.742% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 71.972% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -81416.464% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 187.497% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 185.788% |
| ADMA Biologics, Inc. | 88.21 Million USD | 195.58% |
| Clene Inc. | 533 Thousand USD | 15919.7% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 449.738% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -8710.763% |
| GeoVax Labs, Inc. | -20.72 Million USD | -306.93% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 4341.398% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -43292.721% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 269.298% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -1088.931% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -9986.005% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 201.084% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 115428.537% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 258.608% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 51.314% |
| Trevena, Inc. | 1.45 Million USD | 5895.12% |
| Surrozen, Inc. | -27.23 Million USD | -209.655% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -23786.402% |
| Cingulate Inc. | -582.91 Thousand USD | -14364.985% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -271896.774% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -328.037% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -1113757.332% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -9470.829% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 112.387% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -8434.312% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -149555.674% |
| Kronos Bio, Inc. | 1.37 Million USD | 6245.7% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -57.118% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -28776.37% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -17167.373% |
| ImmunityBio, Inc. | -17.89 Million USD | -371.319% |
| Korro Bio, Inc. | -3.63 Million USD | -2222.837% |
| Kineta, Inc. | 5.43 Million USD | 1651.979% |
| BioVie Inc. | -229.37 Thousand USD | -36660.006% |
| Codexis, Inc. | 57.33 Million USD | 247.066% |
| Celularity Inc. | 6.75 Million USD | 1348.246% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 2201.146% |
| Celcuity Inc. | -142.77 Thousand USD | -58958.499% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 166771.279% |
| Cibus, Inc. | 1.42 Million USD | 6029.606% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -22445.187% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -267.9% |
| IN8bio, Inc. | -2.5 Million USD | -3271.411% |
| Kodiak Sciences Inc. | -25.94 Million USD | -224.966% |
| Annexon, Inc. | -3.26 Million USD | -2480.931% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -4025.196% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -102.025% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 13274.844% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 110.831% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 148.752% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -4337.842% |
| Arcellx, Inc. | 108.27 Million USD | 177.872% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -160.493% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 206.458% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -298.634% |
| Moolec Science SA | -143.3 Thousand USD | -58738.84% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -99.251% |
| Geron Corporation | -123.5 Million USD | 31.727% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 2665.227% |
| Royalty Pharma plc | 1.79 Billion USD | 104.7% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -20.301% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -2334313.068% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 36540.052% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 24.319% |
| Humacyte, Inc. | -76.55 Million USD | -10.149% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -8783.408% |
| 89bio, Inc. | -273 Thousand USD | -30786.081% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -6607.955% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -9843.278% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -68452.033% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 7635.21% |
| Notable Labs, Ltd. | 113 Thousand USD | 74718.584% |
| Liquidia Corporation | 14.6 Million USD | 677.527% |
| Mustang Bio, Inc. | -2.22 Million USD | -3689.618% |
| Immunovant, Inc. | -231 Thousand USD | -36401.732% |
| Quantum-Si incorporated | 488 Thousand USD | 17378.484% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -51.765% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -280963.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 4628.41% |
| Acasti Pharma Inc. | -11 Thousand USD | -766436.364% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -41108.209% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -12903.081% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 49.664% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 7531.737% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -22030.971% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -4206.384% |
| PepGen Inc. | -1.18 Million USD | -7021.537% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -66292.913% |
| United Therapeutics Corporation | 2.07 Billion USD | 104.073% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -268.253% |
| Solid Biosciences Inc. | -76.56 Million USD | -10.13% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -102002.128% |
| Immuneering Corporation | -764.13 Thousand USD | -10934.525% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 127347.072% |
| Belite Bio, Inc | -399 Thousand USD | -21032.581% |
| XOMA Corporation | 3.86 Million USD | 2283.864% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -320.837% |
| Bionomics Limited | -434.44 Thousand USD | -19308.262% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -7750.931% |
| uniQure N.V. | 2.21 Million USD | 3906.727% |
| Cassava Sciences, Inc. | -89.42 Million USD | 5.708% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 8.418% |
| Forte Biosciences, Inc. | -9000.00 USD | -936777.778% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -9998.084% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -19194.966% |
| Altimmune, Inc. | -65.37 Million USD | -28.981% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 123.291% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -7750.931% |
| Compugen Ltd. | 31.45 Million USD | 368.062% |
| Peak Bio, Inc. | 367.76 Thousand USD | 23027.164% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 443.935% |
| Benitec Biopharma Inc. | 108 Thousand USD | 78173.148% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -108001.282% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -6909.061% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -4527.827% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -70756.303% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -6909.061% |
| Instil Bio, Inc. | -4.75 Million USD | -1672.897% |
| argenx SE | 1.1 Billion USD | 107.607% |
| Immunome, Inc. | -8.9 Million USD | -846.66% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -4361.323% |
| Verona Pharma plc | -679.62 Thousand USD | -12306.713% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -48082.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | -3435.388% |
| CervoMed Inc. | -1.29 Million USD | -6418.03% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -3403.074% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -1665.104% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 3512.343% |
| Moolec Science SA | -143.3 Thousand USD | -58738.84% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -20564.902% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -3056.209% |
| AnaptysBio, Inc. | 14.78 Million USD | 670.455% |
| Design Therapeutics, Inc. | -537 Thousand USD | -15601.862% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -19646.838% |
| NeurAxis, Inc. | 2.15 Million USD | 4009.623% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 4029.124% |
| Lumos Pharma, Inc. | 2 Million USD | 4301.246% |
| Achilles Therapeutics plc | -4.73 Million USD | -1682.165% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -48082.286% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -79690.868% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 366.337% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 9880.595% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -8070.446% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -85.121% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 196190.698% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -10157.786% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -640719.273% |
| Palisade Bio, Inc. | 246 Thousand USD | 34376.016% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -255412.121% |
| Beam Therapeutics Inc. | -59.67 Million USD | -41.304% |
| Neurogene Inc. | -3.26 Million USD | -2484.887% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 160.515% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -2183.83% |
| Sesen Bio, Inc. | 40 Million USD | 310.798% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -28290.236% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -1993.822% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -781.445% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 698.857% |
| Athira Pharma, Inc. | -969 Thousand USD | -8601.651% |
| Vaccinex, Inc. | -16 Million USD | -426.862% |
| HCW Biologics Inc. | -574.82 Thousand USD | -14568.664% |
| XOMA Corporation | 3.86 Million USD | 2283.864% |
| Nektar Therapeutics | 53.47 Million USD | 257.67% |
| Arvinas, Inc. | 71.8 Million USD | 217.436% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -1.028% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -34.319% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -26086.025% |
| Rezolute, Inc. | -36 Thousand USD | -234119.444% |
| Clene Inc. | 533 Thousand USD | 15919.7% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -6566800.312% |
| BeyondSpring Inc. | 1.75 Million USD | 4915.477% |
| Synlogic, Inc. | -1.92 Million USD | -4282.484% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -227789.189% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -1231.633% |
| Peak Bio, Inc. | 367.76 Thousand USD | 23027.164% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -344.65% |
| Krystal Biotech, Inc. | 47.6 Million USD | 277.122% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 159.762% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 1777.99% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -3156.542% |
| MannKind Corporation | 136.19 Million USD | 161.912% |
| Ikena Oncology, Inc. | -50.49 Million USD | -66.995% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 177.489% |
| Gossamer Bio, Inc. | -4.38 Million USD | -1822.896% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -33359.921% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1686280.0% |
| Legend Biotech Corporation | 140.92 Million USD | 159.831% |
| Mural Oncology plc | -2.56 Million USD | -3184.729% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -15202.904% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -84219.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 506.278% |
| REGENXBIO Inc. | 53.02 Million USD | 259.005% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1474.01% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -43730.539% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -4768.303% |
| Vaxart, Inc. | -60.76 Million USD | -38.767% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -31987.297% |
| Cellectis S.A. | 18 Thousand USD | 468538.889% |
| Longeveron Inc. | 221 Thousand USD | 38253.394% |
| Repare Therapeutics Inc. | -80.07 Million USD | -5.307% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 107.715% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -6416.151% |
| Revolution Medicines, Inc. | -399.66 Million USD | 78.903% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -240811.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 172179.592% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.98% |
| Denali Therapeutics Inc. | -93.34 Million USD | 9.67% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -336516.232% |
| Veru Inc. | 7.56 Million USD | 1214.457% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -55740.397% |
| Cingulate Inc. | -582.91 Thousand USD | -14364.985% |
| Passage Bio, Inc. | -3.72 Million USD | -2166.031% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -699991.332% |
| Exicure, Inc. | -1.42 Million USD | -5825.439% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -21915.405% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 3219.46% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -16346.872% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 223.769% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -56260.331% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -42.416% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 21664.962% |
| OmniAb, Inc. | 14.66 Million USD | 674.889% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 521.743% |
| Lipocine Inc. | -2.85 Million USD | -2857.712% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -4475.095% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -1377.984% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -5497.79% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 211.954% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -129621.538% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 200.027% |
| Ocugen, Inc. | -33.53 Million USD | -151.421% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -2566.635% |
| Q32 Bio Inc. | 578 Thousand USD | 14688.062% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -31718.491% |
| Alumis Inc. Common Stock | -1.28 Million USD | -6466.9% |
| Equillium, Inc. | 35.95 Million USD | 334.493% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -4839.602% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 16940.93% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -2039546.831% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -32455.598% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 20047.151% |
| Dominari Holdings Inc. | 2.03 Million USD | 4235.311% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -45857.672% |
| vTv Therapeutics Inc. | -13.59 Million USD | -520.221% |
| Bio-Techne Corporation | 773.07 Million USD | 110.907% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 586.858% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 118.299% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -7112.917% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -251.622% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 820.86% |
| Nkarta, Inc. | -5.86 Million USD | -1336.684% |
| BioCardia, Inc. | -7.24 Million USD | -1063.181% |
| Iterum Therapeutics plc | -1.75 Million USD | -4718.229% |